-
IntelGenx Q2 2023: Revenue Decline 67%, Operating Costs Rise, What About Net Loss?
Monday, August 14, 2023 - 10:54pm | 543IntelGenx Technologies Corp. (TSX: IGX) (OTC: IGXT), a drug delivery company focused on the development and manufacturing of pharmaceutical films, reported its financial results on Monday for the second quarter ending on June 30, 2023. IntelGenx: 67% Revenue Dip, Strategic Successes - Can It...